Thomas C Mules

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

African American

Allergic Rhinitis

Ulcerative Colitis

Endothelial Cells

Top Venues

Immunology and cell biology

Alimentary pharmacology & therapeutics

Inflammatory bowel diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Sophia-Louise Noble, Thomas C Mules, Graham Le Gros, Stephen Inns
The immunoregulatory potential of eosinophil subsets. Immunology and cell biology (2024)
Thomas C Mules, Jeffry S Tang, Francesco Vacca, Bibek Yumnam, Alfonso Schmidt, Brittany Lavender, Kate Maclean, Sophia-Louise Noble, Craig Waugh, Roel van Ginkel, Mali Camberis, Graham Le Gros, Stephen Inns
Modulation of intestinal epithelial permeability by chronic small intestinal helminth infections. Immunology and cell biology (2024)
Thomas C Mules, Jeffry S Tang, Francesco Vacca, Bibek Yumnam, Alfonso Schmidt, Brittany Lavender, Kate Maclean, Sophia-Louise Noble, Craig Waugh, Roel van Ginkel, Mali Camberis, Graham Le Gros, Stephen Inns
Modulation of intestinal epithelial permeability by chronic small intestinal helminth infections. Immunology and cell biology 102 (5) (2024)
Sophia-Louise Noble, Francesco Vacca, Kerry L Hilligan, Thomas C Mules, Graham Le Gros, Stephen Inns
Helminth infection induces a distinct subset of CD101 hi lung tissue-infiltrating eosinophils that are differentially regulated by type 2 cytokines. Immunology and cell biology (2024)
Akhilesh Swaminathan, James M Fulforth, Chris M Frampton, Grace M Borichevsky, Thomas C Mules, Kate Kilpatrick, Myriam Choukour, Peter Fields, Resham Ramkissoon, Emily Helms, Stephen B Hanauer, Rupert W Leong, Laurent Peyrin-Biroulet, Corey Allan Siegel, Richard B Gearry
The Disease Severity Index for Inflammatory Bowel Disease Is a Valid Instrument that Predicts Complicated Disease. Inflammatory bowel diseases (2023)
Thomas C Mules, Brittany Lavender, Kate Maclean, Francesco Vacca, Sophia-Louise Noble, Bibek Yumnam, Tama Te Kawa, Alissa Cait, Jeffry Tang, David O'Sullivan, Olivier Gasser, James Stanley, Graham Le Gros, Mali Camberis, Stephen Inns
Controlled Hookworm Infection for Medication-free Maintenance in Patients with Ulcerative Colitis: A Pilot, Double-blind, Randomized Control Trial. Inflammatory bowel diseases (2023)
Thomas C Mules, Stephen Inns, Graham Le Gros
Helminths' therapeutic potential to treat intestinal barrier dysfunction. Allergy (2023)
Akhilesh Swaminathan, Thomas C Mules, Richard Blair Gearry
Editorial: measuring disease severity in inflammatory bowel disease-the whole is greater than the sum of its parts. Authors' reply. Alimentary pharmacology & therapeutics 56 (4) (2022)
Akhilesh Swaminathan, Dali Fan, Grace M Borichevsky, Thomas C Mules, Esther Hirschfeld, Chris M Frampton, Andrew Stewart Day, Corey A Siegel, Richard Blair Gearry
The disease severity index for inflammatory bowel disease is associated with psychological symptoms and quality of life, and predicts a more complicated disease course. Alimentary pharmacology & therapeutics 56 (4) (2022)
Thomas C Mules, Akhilesh Swaminathan, Richard Blair Gearry
Editorial: brain-gut research needs objective measures of disease activity and mental disorders-authors' reply. Alimentary pharmacology & therapeutics 54 (10) (2021)
Thomas C Mules, Akhilesh Swaminathan, Esther Hirschfeld, Grace Borichevsky, Chris Frampton, Andrew Stewart Day, Richard Blair Gearry
The impact of disease activity on psychological symptoms and quality of life in patients with inflammatory bowel disease-results from the Stress, Anxiety and Depression with Disease Activity (SADD) Study. Alimentary pharmacology & therapeutics (2021)